Yes. Contrary to widespread assumptions, investments in facilities for the production of biogenic hydrogen are eligible for funding under the General Block Exemption Regulation (AGVO).

The definition of ‘renewable hydrogen’ in Article 2, paragraph 102c initially refers exclusively to electrolytic hydrogen and forms the basis for the exemption under Article 41, paragraph 3. Biohydrogen, on the other hand, is classified as a biofuel in Article 117a. This means that its production facilities fall under Article 41, paragraph 2 and are therefore explicitly eligible for funding.

It is important to note that paragraph 3 only restricts the promotion of electrolysers – this restriction does not apply to biogenic hydrogen.

If required, we will be happy to provide a statement from the European Commission on this topic upon request.